Volume 10

EXPRESS PRECLINA

Preclina has seized the spotlight with EXPRESS PRECLINA, delivering high-quality, accelerated efficacy testing that slashes costs and removes key barriers in the drug development pathway.

Compressed Timeline	Cost Cut-down
Modular Platform	Win-Win Partnership

Accelerate your preclinical drug
discovery with Pre-VIVO™ Platform!

With deep clinical expertise in inflammatory skin disorders, Preclina creates custom preclinical models and study plans, providing clear, focused efficacy testing that accelerates your drug development toward IND filing.

ATTRACTIVE PRICING	EXTENDED EXPERTISE
VERSATILE PORTFOLIO	RELIABILITY

Customized Psoriasis Efficacy Evaluation to Meet Your Needs

From Market Needs to IND-ready Data,
We Builds the Bridge to Your Breakthrough

With Preclina, robust outcomes are achieved with minimal repeated studies, helping our clients secure highly reproducible and statistically powerful results.

No endless repeats, No wasted time!

The data spoke for itself – leading to a successful licensing deal.

IMQ-induced Psoriasis

IL23-induced Psoriasis

Imiquimod-induced Psoriasis
Psoriasis Induction Model using a TLR Agonist Our robust and proven model provides a true solution for selecting the right lead candidates, cutting through uncertainty to identify compounds with real clinical potential. Try our gold-standard model that accurately reflects the IL-23/IL-17 pathway, a key driver of psoriasis.

State-of-the-Art Pharmacology Support for Atopic Dermatitis

Step-wise Support for Early Drug Discovery

A full-spectrum, modular platform supporting entire process of drug development, from screening and lead selection to optimization, and providing confirmatory studies through a one-stop service.

Experience customized efficacy testing with stage-matched AD models that accurately replicate disease incidence and severity.

Screening Test Models

Confirmatory Test Models

Screening Test Models for Atopic Dermatitis

High Success Probability through Guided Lead Optimization

Experience Guided Lead Optimization through precise, reproducible in vivo results that maximize SAR analysis accuracy.

Our Hapten-Atopy-based Models using genetically predisposed mice offer tailored options for diverse study designs.

Oxazolone-induced AD

DNCB-induced AD

Confirmatory Test Models for Atopic Dermatitis

Rational Selection for the Final Stage of Lead Optimization

Validate your lead compounds in a clinically relevant AD model, precisely mirroring human disease triggered by house dust mites.

From efficacy validation to MOA studies, our comprehensive services support scientific verification through advanced immunological parameters.

House Dust Mite-induced AD

Get in touch with us to find out more
about how we can support you and your research!

[ HO ] 2206, Songdo AIT Center, Yeonsu-gu, Incheon, South Korea
[ BO ] 719 & 1302, Teratower B, Songpa-daero, Songpa-gu, Seoul
[ BO ] 203, 1st Bldg, Chilgokjungang-daero 136-gil, Buk-gu, Daegu
[ Preclina Europe ] Hegenheimermattweg 167A, Basel, Switzerland
[ Preclina US ] CIC Cambridge, One Broadway, Boston, MA, USA